š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
The aim of this clinical study is to demonstrate safety and immunogenicity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691326
The study will evaluate the safety and immunogenicity of the 2014-2015 form...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02222870
The purpose of this study is provide a better understanding of the adaptive...
Status
Completed
Location
Stanford University
Start Date
2014-09-30
Trial ID
NCT03453801
Primary Objective: To provide the Center for Biologics Evaluation and Rese...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00755274
The aim of the study was to describe the safety and immunogenicity of a 0.5...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-23
Trial ID
NCT02915302
Treatments Being Tested
The purpose of this study is to describe the immunogenicity of the prototyp...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00988143
The study will evaluate the safety and immunogenicity of the 2015-2016 form...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02539108